Retractable Technologies (RVP) Cost of Revenue (2010 - 2026)
Retractable Technologies' (RVP) quarterly Cost of Revenue came in at $8.0 million in Q1 2026, down 3.39% YoY from $8.3 million in Q1 2025, and down 26.93% on a QoQ basis from $11.0 million in Q4 2025.
Retractable Technologies (RVP) Cost of Revenue (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Cost of Revenue data on file, last reported at $8.0 million in Q1 2026.
- Quarterly Cost of Revenue fell 3.39% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.9 million (up 3.44% YoY) and the FY2025 annual result came in at $38.2 million, up 12.15% from the prior year.
- Cost of Revenue retreated to $8.0 million in Q1 2026, from $11.0 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $29.2 million in Q1 2022 to a low of $5.7 million in Q1 2024.
- A 5-year average of $10.7 million and a median of $8.4 million in 2025 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue sank 72.13% — and 2024, when it soared 72.28%.
- Tracing RVP's Cost of Revenue over 5 years: stood at $8.4 million in 2022, then soared by 52.2% to $12.7 million in 2023, then retreated by 9.26% to $11.6 million in 2024, then decreased by 5.18% to $11.0 million in 2025, then slipped by 26.93% to $8.0 million in 2026.
- The last three Cost of Revenue figures came in at $8.0 million (Q1 2026), $11.0 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 2.67 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 1.13 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 602.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.47 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 807.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 1.93 Bn |
| 10 | Retractable Technologies | 21.84 Mn | -18.03 Mn | 190,852.00 | 7.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.02 Mn |
| Mar 31, 2026 | 8.02 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Mar 31, 2025 | 8.30 Mn |
| Mar 31, 2025 | 8.30 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | 10.36 Mn |
| Sep 30, 2024 | 10.36 Mn |
| Jun 30, 2024 | 6.45 Mn |
| Jun 30, 2024 | 6.45 Mn |
| Mar 31, 2024 | 5.70 Mn |
| Mar 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 12.75 Mn |
| Dec 31, 2023 | 12.75 Mn |